Aditya Dandekar
Associate Director Cabaletta Bio
I am a senior biotechnology professional with over a decade of experience in immuno-oncology, liver disease, and rare skin disorders. My work has focused on driving innovation in cytokine-based cell therapies—reducing manufacturing times, improving product generation, and achieving significant cost savings. With strong leadership and cross-functional expertise across clinical, quality, and analytical teams, I’m passionate about advancing immunotherapy and shaping the future of biotech through creative, impactful collaboration.
Seminars
Wednesday 25th February 2026
Roundtable Discussion: Is Bigger Always Better? Defining the Right Scale to Effectively Balance Yield, Safety & Cost
11:30 am
- Contrasting scalability limitations across vector types and how physical constraints shape commercial strategy
- Discussing trade-offs between driving higher titres versus maintaining potency and how these challenges can differ across vector classes
- Deciding between ‘scaling up’ and ‘scaling out’ and how this can be affected by modality, indication, and regulatory expectation
Wednesday 25th February 2026
De-Risking Raw & Starting Material Supply: Building Flexible, Standardized, & Resilient Strategies for Viral Vector Manufacturing
9:30 am
- Extending supply chain risk mapping to strengthen continuity of critical raw and starting materials
- Exploring collaborative inventory models to bridge shortages and prevent delays to batch release and clinical timelines
- Standardizing materials across products to streamline inventory, lower cost and accelerate procurement
